Drug Manufacturers - Specialty & Generic · Healthcare
Thomas Smith
Equibles does not estimate personal net worth.
About Thomas Smith
The proxy statement of Collegium Pharmaceutical, Inc reports total compensation of $2,446,008 for Thomas Smith in fiscal 2025, including a base salary of $492,959. Disclosed compensation is on record for 6 fiscal years. Collegium Pharmaceutical, Inc is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Collegium Pharmaceutical, Inc includes Gino Santini (Chairman and Board Member), David Dieter (General Counsel), Shirley Kuhlmann (General Counsel) and 7 others.
Affiliation history
-
Collegium Pharmaceutical, Inc (COLL)
Proxy statement
Current
Company network
Leadership on record at Collegium Pharmaceutical, Inc
- Gino Santini Chairman, Board Member
- David Dieter General Counsel
- Shirley Kuhlmann General Counsel
- Carlos Paya Board Member
- Dr. Rita Balice-Gordon, Ph.D. Board Member
- Garen Bohlin Board Member
- John Fallon Board Member
- John Freund Board Member
- Joseph Ciaffoni Board Member
- Nancy Lurker Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Collegium Pharmaceutical, Inc (COLL) | Executive Vice President and Chief Medical Officer | $492,959 | $2,446,008 |
| 2024 | Collegium Pharmaceutical, Inc (COLL) | Executive Vice President and Chief Medical Officer | $473,496 | $2,500,083 |
| 2023 | Collegium Pharmaceutical, Inc (COLL) | Executive Vice President and Chief Medical Officer | $451,428 | $2,044,802 |
| 2022 | Collegium Pharmaceutical, Inc (COLL) | Executive Vice President and Chief Medical Officer | $318,615 | $600,517 |
| 2021 | Collegium Pharmaceutical, Inc (COLL) | Executive Vice President and Chief Medical Officer | — | — |
| 2020 | Collegium Pharmaceutical, Inc (COLL) | Executive Vice President and Chief Medical Officer | — | — |
Recent activity
No call appearances or filed executive changes recorded yet.